Article
How Bayer And Takeda Pharmaceuticals Use IP E-Learning To Prevent Common IP Risks And Missed IP Opportunities
In today's fast-paced business world, the demand for expedited product and service launches that outperform the competition in terms of quality, speed, and affordability is higher than ever.
Questel
